Efficacy of PBTZ169 and pretomanid against Mycobacterium avium, Mycobacterium abscessus, Mycobacterium chelonae, and Mycobacterium fortuitum in BALB/c mice models

Abstract

PBTZ169 appears to be a candidate for treating four common NTM infections. Pretomanid was more active against <i>M. abscessus</i>, <i>M. chelonae</i> and <i>M. fortuitum</i> than against <i>M. avium</i>.